361 CAPITAL LLC - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 160 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 12.90 and the average weighting 0.1%.

Quarter-by-quarter ownership
361 CAPITAL LLC ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$1,274,000
-41.3%
77,630
-52.5%
0.35%
-12.0%
Q3 2019$2,169,000
-3.3%
163,333
+90.2%
0.40%
-12.6%
Q4 2018$2,244,000
+27.0%
85,885
+11.5%
0.46%
+19.5%
Q3 2018$1,767,000
-17.4%
77,006
-35.6%
0.38%
-6.3%
Q3 2017$2,140,000119,5540.41%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Profit Investment Management, LLC 326,997$1,412,6271.00%
Stonepine Capital Management, LLC 477,903$2,064,5410.69%
Krensavage Asset Management, LLC 360,429$1,5570.57%
Nantahala Capital Management 1,000,000$4,320,0000.37%
Monaco Asset Management SAM 135,000$583,2000.17%
CTC Alternative Strategies, Ltd. 18,400$79,4880.15%
GSA CAPITAL PARTNERS LLP 406,019$1,7540.15%
Sio Capital Management, LLC 97,616$421,7010.13%
HUSSMAN STRATEGIC ADVISORS, INC. 156,000$673,9200.13%
Virtus ETF Advisers LLC 48,530$209,6500.13%
View complete list of VANDA PHARMACEUTICALS INC shareholders